AI , Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence
Although some products, such as those monitoring for arrhythmias, are regulated by the FDA, companies can often label DTC tools as low- risk general ...
Read the original at JAMA Network ↗
- Topics
- HealthcareRegulation & Policy
- Mentions
- FDA
- Tracked via
- “AI Risks”